PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment.

J Immunother Cancer · 2025 · PMC11759878 · PMID 39848686

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As shown in figure 6b , this new combination therapy showed a trend in delaying the tumor growth as compared with HRT+FAP-CD40+PD1-IL2v.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.